Your browser doesn't support javascript.
loading
Study Of 215 Patients Who Required High Flow Nasal Cannula During Corona Virus Epidemic
Article | IMSEAR | ID: sea-219829
ABSTRACT

Background:

High flow nasal cannula is a newer modality of treatment for hypoxemic respiratory failure. Present study is conducted to evaluate demographic characteristics, co-morbidities and outcome parameters of patients on High flow nasal cannula. Material And

Methods:

In retrospective observational study all patients on High flow nasal canula with covid-19 were evaluated for demographic characteristics and outcome with comorbidities during study period.

Result:

Maximum number of patients belongs to age group 51-60 years. Highest mortality was in the age group of 61-70 years.

Conclusion:

The High flow nasal cannula therapy may provide important newer modality and helpful in patients with respiratory failure.

Full text: Available Index: IMSEAR (South-East Asia) Year: 2022 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Year: 2022 Type: Article